###begin article-title 0
###xml 96 109 96 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
IL-4 Deficiency Decreases Mortality but Increases Severity of Arthritis in Experimental Group B Streptococcus Infection
###end article-title 0
###begin p 1
Recommended by Vera L. Petricevich
###end p 1
###begin p 2
###xml 432 433 432 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 769 773 769 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 785 790 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 797 802 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 438 443 <span type="species:ncbi:10090">mouse</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
IL-4 is an anti-inflammatory cytokine that inhibits the onset and severity in different experimental arthritis models. Group B streptococci (GBS) have been recognized as an ever-growing cause of serious invasive infections in nonpregnant adults. Septic arthritis is a clinical manifestation of GBS infection. To investigate the role of IL-4 in experimental GBS infection, IL-4 deficient or competent mice were inoculated with 1 x 107 GBS/mouse. Mortality, appearance of arthritis, GBS growth in the organs, and local and systemic cytokine and chemokine production were examined. IL-4-/- mice showed lower mortality rates but increased severity of arthritis and exhibited a lower microbial load in blood, kidneys, and joints than wt mice. Increased local levels of IL-1 beta, IL-6, TNF-alpha, MIP-1alpha, and MIP-2 accompanied the more severe arthritis in IL-4-/- mice. Our results suggest a detrimental role of IL-4 in GBS sepsis, whereas it plays a beneficial effect on GBS-induced arthritis.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1120 1122 1120 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1123 1125 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1202 1204 1202 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1206 1208 1206 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1315 1317 1315 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1319 1321 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1454 1456 1454 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1458 1460 1458 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1590 1592 1590 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 116 123 <span type="species:ncbi:9606">infants</span>
###xml 138 143 <span type="species:ncbi:9606">women</span>
###xml 723 729 <span type="species:ncbi:9606">humans</span>
###xml 947 955 <span type="species:ncbi:9606">Patients</span>
###xml 1547 1555 <span type="species:ncbi:9606">patients</span>
Group B streptococci (GBS) have long been known as a leading cause of life-threatening infection in neonates, young infants, and pregnant women [1-3]. Recently these microorganisms have been recognized as an ever-growing cause of serious invasive infections in nonpregnant adults [4-6]. GBS is responsible for a wide spectrum of clinical manifestations [5-9]. The most common entities include primary bacteraemia, skin and soft tissue infections, urinary tract infections, and pneumonia. Other relevant conditions are endocarditis, intravascular device infections, meningitis, peritonitis, endoophthalmitis and osteoarticular infections. Bacterial arthritis is a rapidly progressive and highly destructive joint disease in humans with an incidence rate ranging from 0.034% to 0.13% [10]. The typical case of this disease is characterized by high fever and a red, warm, and swollen joint, in 80% to 90% of cases displaying a monoarticular pattern. Patients with primary or secondary immunodeficiencies as well as those who have passed through prosthetic joint surgery display enhanced susceptibility to septic arthritis [10-12]. Septic GBS arthritis in nonpregnant adults was considered extremely rare [13, 14] until the early 1980s, when two independent studies stressed that its incidence seemed to be increasing [15, 16]. This trend has been confirmed by recent studies in which GBS account for 7% to 10% of all diagnosed cases of bacterial arthritis [17, 18]. Interestingly, GBS were typically associated with involvement of multiple joints in patients with diabetes mellitus or cancer [17].
###end p 4
###begin p 5
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 510 514 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 604 606 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 608 610 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 763 765 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 767 769 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 858 862 855 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 889 894 883 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 900 905 890 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 908 910 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
###xml 140 146 <span type="species:ncbi:9606">humans</span>
###xml 157 161 <span type="species:ncbi:10090">Mice</span>
We have previously described an experimental mouse model of type IV GBS infection with clinical features that closely resemble infection in humans [19, 20]. Mice given a single intravenous dose of GBS develop clinical signs of arthritis within 48 hours. Appearance and severity of GBS arthritis are the by-product of a multifactorial process. Viability and number of microorganisms injected and bacterial factors (i.e., presence and amount of capsule, amount of sialic acid in the capsular polysaccharide, and beta-hemolysin production) have been shown to influence the development of articular lesions [21, 22]. Nevertheless, in the pathogenesis of GBS arthritis a crucial role is played by inflammatory cells (granulocytes and monocytes) that reach the joints [23, 24] and by the production of proinflammatory cytokines, including interleukin-6 (IL-6) IL-1beta and tumor necrosis factor-alpha (TNF-alpha) [25].
###end p 5
###begin p 6
###xml 207 212 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 217 221 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 235 237 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 239 241 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 270 275 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 342 344 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 346 348 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 614 616 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 618 620 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 719 721 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 723 725 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
Antiinflammatory cytokines such as IL-4 are known to regulate inflammation. Many of the IL-4 regulatory effects are directed at modulating macrophage activity. IL-4 suppresses proinflammatory cytokines (TNF-alpha IL-1beta, and IL-12) [26, 27] and chemokines (interferon-gamma-inducible protein 10 and macrophage migration inhibitory factor) [28, 29]. The antiinflammatory activity of IL-4 was assessed in vivo in several models of arthritis. It has been demonstrated that systemic administration of IL-4 effectively suppresses disease in proteoglycan-induced arthritis (PGIA) and collagen-induced arthritis (CIA) [30, 31]. Treatment with IL-4 or local expression of IL-4 in CIA prevents cartilage and bone destruction [32, 33].
###end p 6
###begin p 7
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
The aim of our study was to assess the role of IL-4 in our septic arthritis model, both regarding development of the arthritic process and host susceptibility to bacteria. For this purpose, we used Balb/c wild-type mice and Balb/c mice with disrupted IL-4 gene.
###end p 7
###begin title 8
2. Materials and Methods
###end title 8
###begin title 9
###xml 5 9 <span type="species:ncbi:10090">Mice</span>
2.1. Mice
###end title 9
###begin p 10
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
Homozygotous IL-4-/- mice, generated as described elsewhere [34], have been kindly provided by Prof. Luigina Romani, University of Perugia, Perugia, Italy. Control wt Balb/c mice were purchased from Charles River Breeding Laboratories (Calco, Italy). Eight-to-ten week old mice were used for experimental procedures. The animals were maintained and used under strict ethical conditions according to recommendations of European Union's Directive no. 86/609/EEC.
###end p 10
###begin title 11
2.2. Microorganisms
###end title 11
###begin p 12
###xml 719 720 707 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 500 505 <span type="species:ncbi:9940">sheep</span>
###xml 655 659 <span type="species:ncbi:10090">Mice</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
Type IV GBS, ATCC reference strain GBS 3139 (CNCTC 1/82), supplied by J. Jelinkova (Prague, Czech Republic) was used throughout the study. For experimental infection, the microorganisms were grown overnight at 37degreesC in Todd-Hewitt broth (Oxoid Ltd., Basingstoke, Hampshire, England) and then washed and diluted in RPMI 1640 medium (GIBCO, Life Technologies, Milan, Italy). The inoculum size was estimated turbidimetrically, and viability counts were performed by plating on tryptic soy agar -5% sheep blood agar (blood agar), and overnight incubation under anaerobic conditions at 37degreesC. A bacterial suspension was prepared in RPMI 1640 medium. Mice were inoculated intravenously via the tail vein with 1 x 107 GBS in a volume of 0.5 mL. Control mice were injected by the same route with 0.5 mL of RPMI 1640 medium.
###end p 12
###begin title 13
2.3. Clinical Evaluation of Arthritis and Mortality
###end title 13
###begin p 14
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">35</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 743 748 <span type="species:ncbi:10090">mouse</span>
GBS-infected mice were evaluated for signs of arthritis and for mortality. Mortality was recorded at 24-hour intervals for 30 days. After challenge, mice were examined daily by two independent observers (L. T., M. P.) for 30 days to evaluate the presence of joint inflammation, and scores for arthritis severity (macroscopic score) were given as previously described [26, 35]. Arthritis was defined as visible erythema and/or swelling of at least one joint. Clinical severity of arthritis was graded on a scale of 0-3 for each paw, according to changes in erythema and swelling (0 = no change; 1 point = mild swelling and/or erythema; 2 points = moderate swelling and erythema; 3 points = marked swelling, erythema, and/or ankylosis). Thus, a mouse could have a maximum score of 12. The arthritis index (mean +/- SD) was constructed by dividing the total score (cumulative value of all paws) by the number of animals used in each experimental group.
###end p 14
###begin title 15
2.4. Histological Assessment
###end title 15
###begin p 16
###xml 315 317 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
GBS-infected mice were examined 10 days after infection for histopathological features of arthritis. Arthritic hind paws (1 per mouse) were removed aseptically, fixed in formalin 10% v/v for 24 hours and then decalcified in trichloroacetic acid 5% v/v for 7 days, dehydrated, embedded in paraffin, sectioned at 3-4 mum, and stained with hematoxylin and eosin. Samples were examined under blinded conditions. Tibia-tarseal, tarsus-metatarseal, and metatarsus-phalangeal joints were examined, and a histologic score was assigned to each joint based on the extent of infiltrate (presence of inflammatory cells in the subcutaneous and/or periarticular tissues), exudate (presence of inflammatory cells in the articular cavity), cartilage damage, bone erosion, and loss of joint architecture. Arthritis severity was classified as negative (no infiltrate), mild (minimal infiltrate), moderate (presence of infiltrate, minimal exudate, and integrity of joint architecture), and severe (presence of massive infiltrate/exudate, cartilage and bone erosion, and disrupted joint architecture).
###end p 16
###begin title 17
2.5. GBS Growth in Blood, Kidneys, and Joints
###end title 17
###begin p 18
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 639 644 <span type="species:ncbi:10090">mouse</span>
Blood, kidney and joint bacterial load in GBS-infected mice was determined by colony-forming-units (CFU) evaluation at different times after inoculation. Blood samples were obtained by retroorbital sinus bleeding before the mice were killed. Ten-fold dilutions were prepared in RPMI 1640 medium, and 0.1 mL of each dilution was plated in triplicate on blood agar and incubated under anaerobic conditions for 24 hours. The number of CFU was determined, and the results were expressed as the number of CFU per mL of blood. Kidneys were aseptically removed and homogenized with 3 mL of sterile RPMI 1640. All wrist and ankle joints from each mouse were removed, weighed, and homogenized in toto in sterile RPMI 1640 medium (1 mL/100 mg of joint weight). After homogenization, all tissue samples were diluted and plated in triplicate on blood agar, and the results were expressed as the number of CFU per whole organ or per ml of joint homogenate.
###end p 18
###begin title 19
2.6. Sample Preparation for Cytokine Assessment
###end title 19
###begin p 20
###xml 263 265 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 469 471 463 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 675 677 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 314 319 <span type="species:ncbi:10090">mouse</span>
Blood samples from the different experimental groups were obtained by retroorbital sinus bleeding at different times after infection before the mice were killed. Sera were stored at -80degreesC until analyzed. Joint tissues were prepared as previously described [25]. Briefly, all wrist and ankle joints from each mouse were removed and then homogenized in toto in 1 mL/100 mg joint weight of lysis medium (RPMI 1640 containing 2 mM phenylmethylsulfonyl fluoride and 1 mug/mL final concentration of aprotinin, leupeptin, and pepstatin A). The homogenized tissues were then centrifuged at 2000 g for 10 minutes, and supernatants were sterilized using a Millipore filter (0.45 mum) and stored at -80degreesC until analyzed.
###end p 20
###begin title 21
2.7. Cytokine Assays
###end title 21
###begin p 22
###xml 10 14 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 20 25 17 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 66 71 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 450 454 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 475 480 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 524 529 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
IL-6, IL-1beta, TNF-alpha, macrophage inflammatory protein (MIP)-1alpha, and MIP-2 concentrations in the biological samples were measured with commercial ELISA kits purchased from R&D System (R&D Systems Inc., Minneapolis, Minn, USA) according to the manufacturer's recommendations. Results were expressed as picograms per mL of serum or supernatant from joint homogenates. The detection limits of the assays were 1.6 pg/mL for IL-6, 3 pg/mL for IL-1beta, 1.5 pg/mL for MIP-1alpha 1.5 pg/mL for MIP-2, and 5.1 pg/mL for TNF-alpha.
###end p 22
###begin title 23
2.8. Statistical Analysis
###end title 23
###begin p 24
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 338 339 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Differences in the arthritis index, number of CFU, and cytokine concentrations between the groups of mice were analyzed by Student's t-test. The log-rank test was used for data analyses of Kaplan-Meier survival curves. Incidence of arthritis and histologic data were analyzed by Fisher's exact test. Each experiment was repeated 3 times. P-values less than .05 were considered significant.
###end p 24
###begin title 25
3. Results
###end title 25
###begin title 26
3.1. IL-4 Deficiency Decreases Mortality But Increases Severity of GBS-Induced Arthritis
###end title 26
###begin p 27
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 292 304 292 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(a) </xref>
###xml 331 332 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 450 451 450 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 672 673 672 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 794 805 794 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(b)</xref>
###xml 960 971 960 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(c)</xref>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 460 465 <span type="species:ncbi:10090">mouse</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
###xml 1140 1144 <span type="species:ncbi:10090">mice</span>
Balb/c mice defective (IL-4-/-) or intact (wt) with respect to IL-4 gene were injected I.V. with 1 x 107 GBS and the clinical course of disease was followed up to 30 days. The severity of the disease was monitored by assessing both survival rates and clinical score of arthritis. As shown in Figure 1(a) statistically significant (P = .0372) differences were observed in mortality rates between the two experimental groups. In fact, infection with 107 GBS per mouse resulted in a 10% mortality in IL-4-/- mice, while 40% of wt mice had died at the end of observation period. The clinical signs of joint swelling were observed as early as 24 hours after injection of 1 x 107 CFU of GBS in both groups of mice. Although similar frequency of articular lesions was observed in IL-4-/- and wt mice (Figure 1(b)), IL-4 deficient group had a more severe clinical arthritis in affected joints, compared with the control animals, resulting in a higher arthritis index (Figure 1(c)). Significant between-group differences were evident throughout the observation period, with maximum values reached at day 10 after infection of 3.2 +/- 0.5 in IL-4-/- mice versus 2.0 +/- 0.3 in wt animals.
###end p 27
###begin title 28
3.2. Histopathological Findings
###end title 28
###begin p 29
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 390 398 390 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
Arthritic paws were removed for histological examination at day 10 after infection with 1 x 107 GBS per mouse and examined for histopathological features of arthritis. Five arthritic paws from both IL-4-/- mice and BAlb/c mice were removed, and 3 joints for each paw were assessed for histopathological score. Two separate experiments were performed and results were cumulated. As shown in Figure 2, none of the joints from control animals could be classified as severely affected. In this group, 39% of the joints were classified as mildly affected, 32% as moderately affected, and 29% did not show any sign of arthritis. In contrast, In IL4-/- mice only 5% of the joints were negative, while the majority of them were classified as moderately (49%) or severely (31%) affected.
###end p 29
###begin title 30
###xml 39 43 <span type="species:ncbi:10090">Mice</span>
3.3. Lower Bacterial Growth in IL-4-/- Mice
###end title 30
###begin p 31
###xml 190 198 190 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 344 345 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 878 882 <span type="species:ncbi:10090">mice</span>
###xml 1127 1131 <span type="species:ncbi:10090">mice</span>
In vivo GBS growth was assessed 2, 5, and 10 days after GBS infection by quantitative monitoring of bactaeremia and bacterial growth in kidneys and joints of IL-4-/- or wt mice. As shown in Figure 3, a progressive clearance of bacteria was observed in the blood of wt as well as IL-4-/- animals. However, it is noteworthy that a significantly (P < .05) lower number of GBS were recovered in the bloodstream of IL-4-/- mice in comparison to controls, as soon as two days after infection. Such a significant difference was still evident in the following days. A lower streptococcal growth was also observed in the kidneys from IL-4-/- mice with respect to controls. Ten-fold between-group differences in the number of GBS recovered were found at all the time points assessed. Finally, as already assessed in the kidneys and in the blood, bacterial burden in the joints of IL-4-/- mice was significantly lower than in controls, as soon as 2 days after infection. A progressive bacterial growth was then observed in the joints of both experimental groups, although a significantly lower bacterial load was still present in IL-4-/- mice.
###end p 31
###begin title 32
3.4. IL-4 Deficiency Gives Rise to Upregulation of Local Cytokine and Monokine Production
###end title 32
###begin p 33
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 161 165 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 171 176 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 183 188 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 300 308 289 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 363 367 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 376 381 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 535 540 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 658 662 636 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 778 783 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1221 1229 1188 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 1382 1387 1349 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 837 841 <span type="species:ncbi:10090">mice</span>
###xml 1014 1018 <span type="species:ncbi:10090">mice</span>
###xml 1164 1168 <span type="species:ncbi:10090">mice</span>
The role played by cytokines and monokines on the pathogenesis of GBS sepsis and arthritis is well-defined [24, 25]. Thus, local and systemic levels of IL-6, IL1beta, TNF-alpha, MIP-1alpha, and MIP-2 were compared between IL-4-/- and control mice at 2, 5, and 10 days after infection. As depicted in Figure 4, higher levels of proinflammatory cytokines (IL-6, IL1beta and TNF-alpha) were detected in the joints of IL-4-/- mice than in controls. At day 2 after infection significantly higher levels were evident only with regard to TNF-alpha production, but at the other time points assessed differences became statistically significant also for IL-6 and IL-1beta production. On the contrary, serum levels of proinflammatory cytokines were similar in both groups, except for TNF-alpha production which was significantly higher in IL-4-/- mice with respect to controls (52 +/- 10 versus 11 +/- 5 pg/mL of serum) at day 2 after infection. A similar trend was observed for MIP-2 and MIP-1 production in both groups of mice, with peak values reached at day 5 after infection. Again, significantly higher levels of both chemokines were detected in the joints of IL-4-/- mice than in wt animals at all the time points assessed (Figure 5). Differently from the joints, no significant differences were observed between the two experimental groups with respect to systemic production of MIP-1alpha and MIP-2 (data not shown).
###end p 33
###begin title 34
4. Discussion
###end title 34
###begin p 35
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 240 244 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 261 266 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 305 307 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 309 311 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">36</xref>
###xml 710 732 703 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus </italic>
###xml 744 746 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">37</xref>
###xml 1089 1100 1082 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania </italic>
###xml 1102 1104 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">38</xref>
###xml 1165 1182 1158 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans </italic>
###xml 1184 1186 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">39</xref>
###xml 4 10 <span type="species:ncbi:10090">murine</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 694 700 <span type="species:ncbi:10090">murine</span>
###xml 710 731 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 815 819 <span type="species:ncbi:10090">mice</span>
###xml 1165 1181 <span type="species:ncbi:5476">Candida albicans</span>
###xml 1301 1305 <span type="species:ncbi:10090">mice</span>
The murine model of GBS infection has proven to be beneficial in elucidating bacterial and host factors responsible for GBS arthritis [19-25]. Our previous studies pointed out a major role for proinflammatory cytokines such as of IL-6, IL-1beta, IL-18, and TNF-alpha in the pathogenesis of GBS arthritis [25, 36]. In this study, by using deficient mice, we found that the antiinflammatory cytokine IL-4 has a relevant influence on GBS-induced sepsis and septic arthritis. The first effect of IL-4 absence on the course of GBS infection is the decrease of mortality rates. This result is in line with a paper by Hultgren et al., who described a beneficial effect of IL-4 lack in an experimental murine model of Staphylococcus aureus  infection [37]. In this paper, the diminished mortality rates observed in IL-4-/- mice were associated to an increased systemic bacterial clearance, attributable to an enhanced intracellular killing capacity mediated by phagocytic cells. It has been demonstrated that IL-4 acts on phagocytes by suppression of oxidative bursts and intracellular killing of Leishmania  [38], and inhibits peritoneal and splenic macrophage killing of Candida albicans  [39]. Actually, in our experimental model a lower number of GBS were recovered both from blood and kidneys of IL-4-/- mice compared to controls, thus suggesting that IL-4 exerts an inhibitory effect also on GBS killing by phagocytes.
###end p 35
###begin p 36
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">35</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1176 1178 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 1309 1311 1309 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 1376 1378 1376 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1413 1415 1413 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1784 1789 1784 1785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1853 1855 1849 1851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 1857 1859 1853 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 2030 2032 2026 2028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 2033 2035 2029 2031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 2117 2122 2113 2114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 2315 2317 2307 2309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 2606 2610 2598 2599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 2620 2625 2609 2610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 1288 1291 <span type="species:ncbi:10116">rat</span>
###xml 1407 1411 <span type="species:ncbi:10090">mice</span>
###xml 1427 1431 <span type="species:ncbi:10090">mice</span>
###xml 2391 2395 <span type="species:ncbi:10090">mice</span>
Lack of IL-4 also results in a worsening of articular lesions. This was apparently in contrast with the lower bacterial load found in the joints of IL-4-/- mice with respect to controls. However, it must be considered that severity of GBS arthritis is not exclusively linked to the amount of bacteria present in the joints, but is also dictated by other parameters, including proinflammatory cytokine production and the extent of inflammatory infiltrate/exudates in the articular tissues. The recruitment and activation of inflammatory cells at infection sites is a complex and dynamic process that involves the coordinated expression of both pro- and antiinflammatory mediators. Indeed, although an inflammatory response is essential to clear pathogens from the site of infection, a prolonged inflammatory response might lead to a detrimental outcome [35]. In this respect, a beneficial effect of IL-4 has been demonstrated in many experimental model of arthritis. Administration of exogenous IL-4 resulted in suppression of CIA [30], while, in the same experimental model, administration of anti-IL4 monoclonal antibodies augmented both incidence and severity of arthritis [40]. Daily treatment with IL-4 was reported to reduce all disease parameters in a streptococcal cell wall (SCW) rat arthritis model [41]. In the PGIA model, arthritis was prevented by IL-4 treatment [31] and exacerbated in IL-4-/- mice [27]. In these mice, the rapid induction of arthritis parallels in vivo increase of proinflammatory cytokine and chemokine secretion. It is well known that proinflammatory cytokines and chemokines play a critical role in the pathogenesis of arthritis. Resident synovial macrophages and fibroblasts as well as infiltrate cells produce proiflammatory cytokines, such as TNF-alpha, IL-1, IL-6, IL-15, and IL-17 that drive disease pathogenesis [42, 43]. These cytokines initiate a cascade of events that induce cartilage-degrading enzymes, such as metalloproteases, and that stimulate osteoclastogenesis and angiogenesis [44-46]. Recruitment of cells to the synovial tissues involves chemokines, such as MIP-1alpha responsible for recruitment of mononuclear cells and MIP-2 that acts on neutrophils. All these inflammatory cells contribute to articular damage by cytokine and proteolytic enzyme production [11]. In our model, despite the lower number of GBS in the joints of IL-4-/- mice, all the other parameters leading to an exacerbation of articular lesions are manifested. In fact, worsening of joint disease was associated with a marked increase of local proinflammatory cytokines (IL-6, IL-1beta, and TNF-alpha) responsible for articular damage, together with sustained levels of monokines and a consequent enhanced inflammatory cell influx.
###end p 36
###begin p 37
In conclusion, we propose that IL-4 plays a dual role in the immune response to GBS infection. By one side, by inhibiting the intracellular killing of phagocytes, IL-4 may cause a more severe systemic infection and, consequently, higher mortality rates. By the other side, by downregulating local levels of proinflammatory cytokines and chemokines, it appears to positively influence the progression of GBS arthritis.
###end p 37
###begin title 38
Acknowledgments
###end title 38
###begin p 39
The authors wish to thank Stefano Temperoni and Alessandro Braganti for their excellent technical assistance in histological processing and animal care. This work was supported by the Ministero dell'Universita e della Ricerca Scientifica 2007-2008, Prot. 2007XYB9T9_002, Italy.
###end p 39
###begin article-title 40
###xml 0 21 <span type="species:ncbi:1319">Group B streptococcus</span>
Group B streptococcus
###end article-title 40
###begin article-title 41
Maternal peripartum complications associated with vaginal group B streptococci colonization
###end article-title 41
###begin article-title 42
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
###end article-title 42
###begin article-title 43
Risk factors for group B streptococcal disease in adults
###end article-title 43
###begin article-title 44
Invasive group B streptococcal disease in nonpregnant adults
###end article-title 44
###begin article-title 45
Group B streptococcal disease in nonpregnant adults
###end article-title 45
###begin article-title 46
Group B streptococcal bacteremia in adults: five years' experience and a review of the literature
###end article-title 46
###begin article-title 47
Group B streptococcal osteomyelitis in adults
###end article-title 47
###begin article-title 48
Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults
###end article-title 48
###begin article-title 49
Adult septic arthritis
###end article-title 49
###begin article-title 50
Bacterial arthritis
###end article-title 50
###begin article-title 51
Nongonococcal bacterial arthritis
###end article-title 51
###begin article-title 52
Serious infections in adults due to group B streptococci: clinical and serotypic characterization
###end article-title 52
###begin article-title 53
###xml 23 36 23 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. agalactiae</italic>
###xml 0 21 <span type="species:ncbi:1319">Group B streptococcus</span>
###xml 23 36 <span type="species:ncbi:1311">S. agalactiae</span>
Group B streptococcus (S. agalactiae) bacteremia in adults: analysis of 32 cases and review of the literature
###end article-title 53
###begin article-title 54
Group B streptococcal arthritis in adults
###end article-title 54
###begin article-title 55
###xml 0 21 <span type="species:ncbi:1319">Group B streptococcus</span>
Group B streptococcus arthritis in adults
###end article-title 55
###begin article-title 56
###xml 23 47 23 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus agalactiae</italic>
###xml 0 21 <span type="species:ncbi:1319">Group B streptococcus</span>
###xml 23 47 <span type="species:ncbi:1311">Streptococcus agalactiae</span>
Group B streptococcus (Streptococcus agalactiae) pyogenic arthritis in nonpregnant adults
###end article-title 56
###begin article-title 57
Streptococcal septic arthritis in adults. A study of 55 cases with a literature review
###end article-title 57
###begin article-title 58
###xml 30 54 30 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus agalactiae</italic>
###xml 64 77 64 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">streptococcus</italic>
###xml 30 54 <span type="species:ncbi:1311">Streptococcus agalactiae</span>
###xml 56 77 <span type="species:ncbi:1319">group B streptococcus</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis
###end article-title 58
###begin article-title 59
###xml 21 34 21 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Experimental group B Streptococcus arthritis in mice
###end article-title 59
###begin article-title 60
Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis
###end article-title 60
###begin article-title 61
###xml 63 67 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Severity of group B streptococcal arthritis is correlated with beta-hemolysin expression
###end article-title 61
###begin article-title 62
###xml 24 29 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Influence of interferon-gamma administration on the severity of experimental group B streptococcal arthritis
###end article-title 62
###begin article-title 63
Role of macrophages in experimental group B streptococcal arthritis
###end article-title 63
###begin article-title 64
###xml 50 54 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
Role of tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 in a mouse model of group B streptococcal arthritis
###end article-title 64
###begin article-title 65
###xml 47 51 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 75 80 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 94 99 <span type="species:ncbi:9606">human</span>
Interleukin-4 (IL-4) inhibits secretion of IL-1beta, tumor necrosis factor alpha, and IL-6 by human monocytes
###end article-title 65
###begin article-title 66
IL-4 and IL-12 regulate proteoglycan-induced arthritis through stat-dependent mechanisms
###end article-title 66
###begin article-title 67
###xml 53 58 <span type="species:ncbi:9606">human</span>
IL-4 inhibits the expression of IL-8 from stimulated human monocytes
###end article-title 67
###begin article-title 68
Anti-inflammatory action of IL-4: negative regulation of contact sensitivity to trinitrochlorobenzene
###end article-title 68
###begin article-title 69
Suppression of collagen-induced arthritis by continuous administration of IL-4
###end article-title 69
###begin article-title 70
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines
###end article-title 70
###begin article-title 71
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction
###end article-title 71
###begin article-title 72
###xml 101 107 <span type="species:ncbi:10090">murine</span>
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
###end article-title 72
###begin article-title 73
###xml 18 24 <span type="species:ncbi:10090">murine</span>
Disruption of the murine IL-4 gene blocks Th2 cytokine responses
###end article-title 73
###begin article-title 74
Neutrophils, host defense, and inflammation: a double-edged sword
###end article-title 74
###begin article-title 75
Role of interleukin-18 in experimental group B streptococcal arthritis
###end article-title 75
###begin article-title 76
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 0 21 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth
###end article-title 76
###begin article-title 77
###xml 23 28 <span type="species:ncbi:9606">human</span>
Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity
###end article-title 77
###begin article-title 78
###xml 86 102 86 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 86 102 <span type="species:ncbi:5476">Candida albicans</span>
Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans
###end article-title 78
###begin article-title 79
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Effect of a monoclonal antibody against interleukin-4 on collagen-induced arthritis in mice
###end article-title 79
###begin article-title 80
Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis
###end article-title 80
###begin article-title 81
Pathogenesis of rheumatoid arthritis: targeting cytokines
###end article-title 81
###begin article-title 82
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
###end article-title 82
###begin article-title 83
Chemokines and angiogenesis
###end article-title 83
###begin article-title 84
###xml 48 53 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 79 84 <span type="species:ncbi:9606">human</span>
Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage
###end article-title 84
###begin article-title 85
###xml 30 38 <span type="species:ncbi:9606">patients</span>
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
###end article-title 85
###begin p 86
###xml 0 55 0 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mortality rates, incidence, and severity of arthritis. </italic>
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 234 243 234 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="sec2">Section 2</xref>
###xml 521 522 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 110 115 <span type="species:ncbi:10090">mouse</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
Mortality rates, incidence, and severity of arthritis.  IL-4-deficient and wt mice were infected with 107 GBS/mouse. Mortality (a), incidence (b), and severity (c) of arthritis were evaluated as detailed in materials and methods (see Section 2). Ten mice were used in each experimental group. (a) The data are the cumulative results of three separate experiments. (b) and (c) Data represent the mean +/- SD of three separate experiments. Statistical differences between the experimental groups were marked with asterisk (P < .05).
###end p 86
###begin p 87
###xml 0 28 0 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Histopathological findings. </italic>
###xml 233 242 233 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="sec2">Section 2</xref>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
Histopathological findings.  Histophatolgical severity of arthritis was assessed in IL-4-/- mice or controls 10 days after infection. Arthritis was defined negative, mild moderate, or severe as detailed in Materials and Methods (see Section 2). Cumulative results of two independent experiments are represented. For each experimental group, 5 arthritic paws from IL-4-/- mice or control mice were removed, and 3 joints for each paw were assessed for histopathological score.
###end p 87
###begin p 88
###xml 0 47 0 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacterial growth in blood, kidneys and joints. </italic>
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 204 213 204 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="sec2">Section 2</xref>
###xml 578 579 576 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
Bacterial growth in blood, kidneys and joints.  IL-4-deficient and wt mice were infected with 1 x 1076 GBS/mouse, and blood and organs were removed and processed as detailed in materials and methods (see Section 2). The values represent the mean +/- SD of three separate experiments each consisting of 20 mice per experimental group. Three mice per group were sacrificed at each time point. Results are expressed as number of CFU per ml of blood, per whole organ, or per ml of joint homogenate. Statistical differences between the experimental groups were marked with asterisk (P < .05).
###end p 88
###begin p 89
###xml 0 39 0 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cytokine production in joints, and sera</italic>
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 228 233 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 249 253 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 305 314 298 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="sec2">Section 2</xref>
###xml 565 566 556 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
Cytokine production in joints, and sera. IL-4-deficient or wt mice infected with 1 x 107 GBS/mouse. Supernatants from joint homogenates, or blood samples were collected at the indicated times after infection and assayed for TNF-alpha, IL-6, and IL-1beta by ELISA as detailed in materials and methods (see Section 2). Values are the mean +/- SD of three separate experiments each consisting of 20 mice per experimental group. Three mice per group were sacrificed at each time point. Statistical differences between the experimental groups were marked with asterisk (P < .05).
###end p 89
###begin p 90
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chemokine production in joints</italic>
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 202 207 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 269 278 265 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="sec2">Section 2</xref>
###xml 529 530 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
Chemokine production in joints. IL-4-deficient or wt mice infected with 1 x 107 GBS/mouse. Supernatants from joint homogenates were collected at the indicated times after infection and assayed for Mip-1alpha and MIP-2 by ELISA as detailed in materials and methods (see Section 2). Values are the mean +/- SD of three separate experiments each consisting of 20 mice per experimental group. Three mice per group were sacrificed at each time point. Statistical differences between the experimental groups were marked with asterisk (P < .05).
###end p 90

